Abiopharma

GANNETT CO., INC. (TDAY) Announces Regulatory Update GANNETT CO., INC. (TDAY) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

• anticipated by the Company's forward-looking statements will occur. Except to the extent required by law, the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.Use of Website to Distribute Material Company InformationThe Company's website is www.usatodayco.com. Information contained on the Company's website is not part of this Current Report on Form 8-K. The Company uses its website as a distribution channel for material company information. Financial and other important information regarding the Company is routinely posted on and accessible on the Investor Relations and News and Events subpages of the Company's website, which are accessible by clicking on the tab labeled "Investor Relations" and "News and Events", respectively, on the website home page. Therefore, investors should look to the Investor Relations, and News and Events subpages of the Company's website for important and time-critical information.SIGNATURE Pursuant to requirements of the Securities Exchange Act of 1934